Humana Rg
HUM
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Official
09/16/2026 - 02:04:00
396.62
-10.40 ( -2.56% )
More information
Analysis by TheScreener
15.09.2026
Evaluation Neutral  
Quality Very strong  
Risk High  
Analysis date: 15.09.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 07.08.2026.
Quality
  Very strong
Four stars since 01.09.2026.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.07.2026 at a price of 392.22.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 07.08.2026.
4wk Rel Perf
  4.52%
 
The four-week dividend-adjusted overperformance versus SP500 is 4.52%.
Risk
  High
High, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.41%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.50%.
Mkt Cap in $bn
  48.88
With a market capitalization >$8bn, HUMANA is considered a large-cap stock.
G/PE Ratio
  1.67
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  13.98
The estimated PE is for the year 2028.
LT Growth
  22.46%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  24
Over the last seven weeks, an average of 24 analysts provided earnings per share estimates.
Dividend Yield
  0.93%
The twelve month estimated dividend yield represents 13.01% of earnings forecasts.
Beta
  61
For 1% of index variation, the stock varies on average by 0.61%.
Correlation
  0.15
Stock movements are totally independent of index variations.
Value at Risk
  104.18
The value at risk is estimated at USD 104.18. The risk is therefore 26.27%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002